Evidence map›Paper›PMID 31488217›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells.

Yu Mao, Yimin Wang, Lixin Dong, Yunjie Zhang, Yanqiu Zhang, Chao Wang, Qiang Zhang, Sen Yang, Liyan Cao, Xinyuan Zhang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 131 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Biogenesis and functional implications of extracellular vesicles in cancer metastasis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yu MaoDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China. ayabluewin@163.com.
Yimin WangDepartment of General Surgery, First Hospital of Qinhuangdao, Hebei Medical University, Qinhuangdao, China.
Lixin DongDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Yunjie ZhangDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Yanqiu ZhangDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Chao WangDepartment of Thoracic Surgery, First Hospital of Qinhuangdao, Qinhuangdao, China.
Qiang ZhangDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Sen YangDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Liyan CaoDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Xinyuan ZhangDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Xin LiDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China.
Zhanzhao FuDepartment of Oncology, First Hospital of Qinhuangdao, Wenhua Road No. 258, Haigang District, Qinhuangdao, 066000, Hebei, China. doctors12email@163.com.
First Hospital of Qinhuangdao · CN

Funding

Scientific Research Fund of Hebei Health and Family Planning Commission 20181192
6 · The paper itself

Abstract

backgroundIn cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC).

methodsDifferential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs.

resultsExosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs.

conclusionsTaken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.

Indexed as

TranscriptomeAnimalsCell CycleCell Line, TumorComputational BiologyDisease Models, AnimalDisease ProgressionEndothelial CellsEsophageal Squamous Cell CarcinomaExosomesGene Expression ProfilingHumansHypoxiaMiceMolecular Sequence AnnotationNeoplasm MetastasisAngiogensisESCCExosomesMetastasis

Identifiers

PMID31488217
PMCPMC6727585
OpenAlexW2972290676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.